Search - tctmd.com

Displaying 461 - 480 of 506

Sort: Relevancy | Date

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

Presentation TCT 2016

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Presenter: Howard C. Herrmann, Sherif F. Nagueh, Robert Roberts

October 30, 2016

News Industry News

Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy

August 31, 2016

News Conference News ESC 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Shelley Wood

August 28, 2016

News Daily News

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Michael O'Riordan

August 24, 2016

News Daily News

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Yael L. Maxwell

August 23, 2016

News Daily News

难辨心绞痛：能够正确识别胸痛的医师差异很大

Yael L. Maxwell

August 18, 2016

News Daily News

Angina Ambigua: La Capacidad de los Médicos a la hora de Identificar Correctamente el Dolor Torácico Varía Enormemente

Yael L. Maxwell

August 18, 2016

News Daily News

Ambiguous Angina: Physicians’ Ability to Properly Identify Chest Pain Varies Widely

Yael L. Maxwell

August 18, 2016

News Daily News

Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure

Todd Neale

July 25, 2016

News Daily News

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

Michael H. Wilson

July 13, 2016

News Daily News

Imagining the Unimaginable: Video May Help Heart Failure Patients With End-of-Life Decisions

Leah Lawrence

July 07, 2016

News Industry News

Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure

June 27, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Industry News

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

May 04, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

News Daily News

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

Michael O'Riordan

April 29, 2016

News Industry News

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

April 20, 2016

News Industry News

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

April 19, 2016

Advertisement

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

难辨心绞痛：能够正确识别胸痛的医师差异很大

Angina Ambigua: La Capacidad de los Médicos a la hora de Identificar Correctamente el Dolor Torácico Varía Enormemente

Ambiguous Angina: Physicians’ Ability to Properly Identify Chest Pain Varies Widely

Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

Imagining the Unimaginable: Video May Help Heart Failure Patients With End-of-Life Decisions

Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content